BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10934653)

  • 1. Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.
    Abrahamsen B; Bonnevie-Nielsen V; Ebbesen EN; Gram J; Beck-Nielsen H
    J Bone Miner Res; 2000 Aug; 15(8):1545-54. PubMed ID: 10934653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
    Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
    Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of interleukin-1 and -6 in the etiopathogenesis of idiopathic osteoporosis and osteopenia in children.
    Rusińska A; Chlebna-Sokół D
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):257-65. PubMed ID: 15995586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women--implications for assessment of bone loss and response to therapy: The Danish Osteoporosis Prevention Study.
    Abrahamsen B; Stilgren LS; Hermann AP; Tofteng CL; Bärenholdt O; Vestergaard P; Brot C; Nielsen SP
    J Bone Miner Res; 2001 Jul; 16(7):1212-9. PubMed ID: 11450696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood.
    Rogers A; Eastell R
    J Bone Miner Res; 1998 Oct; 13(10):1577-86. PubMed ID: 9783546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1.
    D'Elia HF; Mattsson LA; Ohlsson C; Nordborg E; Carlsten H
    Arthritis Res Ther; 2003; 5(4):R202-9. PubMed ID: 12823855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women.
    Insogna K; Mitnick M; Pascarella J; Nakchbandi I; Grey A; Masiukiewicz U
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N108-16. PubMed ID: 12412787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
    Legroux-Gerot I; Vignau J; Collier F; Cortet B
    Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women.
    Abrahamsen B; Shalhoub V; Larson EK; Eriksen EF; Beck-Nielsen H; Marks SC
    Bone; 2000 Feb; 26(2):137-45. PubMed ID: 10678408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential early posttransplant cytokine responses in living and cadaver donor renal allografts.
    Sadeghi M; Daniel V; Weimer R; Wiesel M; Hergesell O; Opelz G
    Transplantation; 2003 Apr; 75(8):1351-5. PubMed ID: 12717229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of raloxifene and estrogen on interleukin-1beta and interleukin-1 receptor antagonist production using in vitro and ex vivo studies.
    Rogers A; Clowes JA; Pereda CA; Eastell R
    Bone; 2007 Jan; 40(1):105-10. PubMed ID: 16934544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women.
    McKane WR; Khosla S; Peterson JM; Egan K; Riggs BL
    J Bone Miner Res; 1994 Aug; 9(8):1313-8. PubMed ID: 7976512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?
    Sirola J; Kröger H; Honkanen R; Sandini L; Tuppurainen M; Jurvelin JS; Saarikoski S
    Osteoporos Int; 2003 Jan; 14(1):27-33. PubMed ID: 12577182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
    Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G
    J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine production by whole blood cells: relationship to interleukin gene polymorphism and bone mass.
    Kim JG; Ku SY; Lim KS; Jee BC; Suh CS; Kim SH; Choi YM; Moon SY
    J Korean Med Sci; 2005 Dec; 20(6):1017-22. PubMed ID: 16361815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A; Urbańska-Ryś H; Robak T
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.